For thousands of years, humans have shaped dogs through selective breeding to fulfill various roles and preferences, resulting in the wide range of breeds known today. Now, advances in genetic engineering are opening a new chapter in the development of canine companions. In August, Kindred Companion Sciences, a New York-based biotech company, announced the creation of the first gene-edited hypoallergenic dogs using CRISPR technology.
The company focused on disabling a gene called Can f 1, responsible for producing one of the main proteins triggering allergic reactions in humans. By editing this gene in canine cells and cloning the altered genomes into embryos implanted in a surrogate beagle, Kindred introduced two puppies—Alfie and Bailey—who reportedly produce no detectable levels of the allergen. Bailey was adopted by Matt Walker, Kindred’s CEO, who has suffered from dog allergies his entire life, and he reports no allergic reactions to the dog. The puppies are now nearly two years old and appear to be developing normally.
Despite this promising development, experts caution that it remains too early to confirm whether a single gene edit will reliably prevent allergic responses in humans or if the dogs’ health might be affected over time. Genetic interventions can have unforeseen consequences, and potential medical issues could emerge as the animals age or as gene editing efforts expand.
The ethical considerations surrounding gene editing in dogs are complex and contested. Critics warn about the risks of prioritizing human convenience over animal welfare, drawing lessons from the history of selective breeding, which has produced dogs with inherited diseases and problematic physical traits. Rowena Packer, an animal welfare specialist at the Royal Veterinary College in London, notes that unintended health problems have often accompanied efforts to breed for specific characteristics. Similarly, bioethicists emphasize concerns about using gene editing alongside—or instead of—addressing broader issues such as pet overpopulation and current breeding practices.
Lisa Moses, a veterinarian and bioethicist at Harvard University, highlights the number of animals involved in the research process, including test subjects and surrogate mothers, adding an additional layer to the ethical debate. Jessica Pierce, a bioethicist at the University of Colorado Anschutz Medical Campus, questions whether it is appropriate to employ biotechnology to create animals that better suit human preferences, rather than changing human behavior toward existing animals.
Walker, however, defends the application of gene editing as a necessary tool for expanding access to pet companionship, particularly for allergy sufferers like himself. He also sees potential benefits in developing hypoallergenic service dogs. “For me, this feels justified by the potential benefits, as long as animal health is protected,” he said.
While gene editing offers a novel approach to tackling allergies, experts agree that improving canine welfare overall will require broad reforms. These could include revising breed standards, increasing genetic diversity in breeding programs, and educating the public on the health consequences of breeding for extreme physical traits. Alison Van Eenennaam, an animal genomics expert at the University of California, Davis, stresses that ethical challenges are not unique to new genetic tools but are rooted in the longstanding human desire to create companion animals.
Research also suggests that gene editing might one day help remedy inherited health problems caused by selective breeding. A 2022 study demonstrated that it is technically feasible to correct a genetic mutation linked to hip issues in Labrador retrievers, though most canine health problems likely involve multiple genetic and environmental factors.
As the debate continues, Kindred’s experiment with hypoallergenic beagles offers a glimpse of the possibilities and challenges posed by gene editing in pets. For Walker, living with a gene-edited dog has been a life-changing experience, bringing companionship that was previously out of reach due to his allergies. Though humans cannot yet edit their own genomes to remove allergic sensitivities, advances in biotechnology may soon reshape the way people and dogs live together.